This product has been discontinued.
COVID‑SeroKlirTM
• Enabling clinical testing
• 2-phase orthogonal SARS-CoV-2 IgG antibody ELISA
Choose Your Kit

COV219-100 EUA
- Available in the US Only
- Emergency Used Authorized
- View Product Insert
- Certificate of Analysis Lookup
Learn More

COV219-CA100
- Available in Canada only
- Health Canada COVID-19 Interim Use
- COMING SOON!

CVD2-2019 CE-IVD
- Available in the EU and UK Only
- CE-IVD
- View Product Insert
- Certificate of Analysis Lookup
Deutsch
Español
Français
Italiano
Português
Learn More
About Us
R&D Systems
R&D Systems is a premier brand of Bio-Techne Corporation, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne’s brand, R&D Systems, provides the tools needed for scale up, validation, and continuous supply of the Kantaro Biosciences COVID-SeroIndex ELISA.

614 McKinley Place NE, Minneapolis, MN 55413 USA
800-343-7475 | Bio-Techne.com
Kantaro Biosciences
Kantaro Biosciences ("Kantaro"), a Mount Sinai Health System venture, is dedicated to ensuring that diagnostic tests for critical health challenges are accessible to all. The company provides academically rigorous, validated and results-driven diagnostics to advance the wellbeing of people, communities and society. Kantaro specializes in the rapid scaleup of groundbreaking diagnostic innovations and the creation of partnerships to bring these crucial technologies to market. The company is majority owned and controlled by Mount Sinai.
For more information, visit www.kantarobio.com.

1460 Broadway, New York, NY 10036
info@kantarobio.com | 646-809-8219 | KantaroBio.com